Purchases and Sales Made in Q4 2021 in Cyma Bay Therapeutics, Inc. (CBAY)
This table provides information about the institutional ownership of Cyma Bay Therapeutics, Inc. (CBAY) during Q4 2021. The information is specifically focused on institutions that hold shares of CymaBay Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-65.6K- 85.81% |
$212K - $302K
|
10.8K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Morgan Stanley
New York, NY |
SELL
|
- |
-69.1K- 38.4% |
$223K - $318K
|
111K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-81.6KClosed |
$264K - $375K
|
0
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-83.4K- 73.01% |
$269K - $384K
|
30.8K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-102K- 29.23% |
$329K - $469K
|
247K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-115KClosed |
$371K - $529K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-197K- 51.23% |
$635K - $904K
|
187K
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-297K- 57.94% |
$959K - $1.37M
|
216K
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-302KClosed |
$975K - $1.39M
|
0
$0
|
|
|
Jan 21, 2022
Q4 2021
|
Kestra Private Wealth Services, LLC
|
SELL
|
- |
-501KClosed |
$1.62M - $2.3M
|
0
$0
|